Richard Hill

3.4k total citations
48 papers, 2.6k citations indexed

About

Richard Hill is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Richard Hill has authored 48 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Oncology and 7 papers in Hematology. Recurrent topics in Richard Hill's work include Cancer-related Molecular Pathways (8 papers), Cancer Research and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Richard Hill is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Cancer Research and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Richard Hill collaborates with scholars based in United States, Canada and Portugal. Richard Hill's co-authors include Patrícia A. Madureira, J Levin, Wolfgang Link, Patrick W. Lee, Nuria de Pedro, Bastien Cautain, Carman A. Giacomantonio, Ana Rita Monteiro, Patrick W.K. Lee and Louis B. Harrison and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Biotechnology.

In The Last Decade

Richard Hill

47 papers receiving 2.5k citations

Peers

Richard Hill

ONCOL

GENET

HEMAT

Germán Pihán United States

Andrew M. Stern United States

Akulapalli Sudhakar United States

Nancy Krett United States

Jianmin Sun China

Ali Bettaı̈eb France

Marc Navre United States

Robert S. Stearman United States

David Brankow United States

Oi Lian Kon Singapore

Germán Pihán United States

Richard Hill

2.3k ×1.7

1.0k ×1.6

ONCOL

500 ×1.1

340 ×0.9

GENET

347 ×1.1

HEMAT

Citations per year, relative to Richard Hill Richard Hill (= 1×) peers Germán Pihán

Countries citing papers authored by Richard Hill

Since Specialization

Citations

This map shows the geographic impact of Richard Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hill more than expected).

Fields of papers citing papers by Richard Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hill. The network helps show where Richard Hill may publish in the future.

Co-authorship network of co-authors of Richard Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hill. A scholar is included among the top collaborators of Richard Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hill. Richard Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Howarth, Alison, Patrícia A. Madureira, Simon M. Cragg, et al.. (2019). DIVERSet JAG Compounds Inhibit Topoisomerase II and Are Effective Against Adult and Pediatric High-Grade Gliomas. Translational Oncology. 12(10). 1375–1385. 2 indexed citations

Howarth, Alison, Patrícia A. Madureira, Lisa Storer, et al.. (2019). Modulating autophagy as a therapeutic strategy for the treatment of paediatric high‐grade glioma. Brain Pathology. 29(6). 707–725. 12 indexed citations

Hill, Richard, Ravi Kiran Reddy Kalathur, Ricardo Brandão, et al.. (2015). TRIB2 as a biomarker for diagnosis and progression of melanoma. Carcinogenesis. 36(4). 469–477. 30 indexed citations

Ferreira, Bibiana I., Richard Hill, & Wolfgang Link. (2015). Special Review. The Cancer Journal. 21(6). 441–447. 7 indexed citations

Tarrado‐Castellarnau, Míriam, R. Cortès, Míriam Zanuy, et al.. (2015). Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition. Pharmacological Research. 102. 218–234. 40 indexed citations

Mori, Mattia, Gianluca Vignaroli, Ylenia Cau, et al.. (2014). Discovery of 14‐3‐3 Protein–Protein Interaction Inhibitors that Sensitize Multidrug‐Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693. ChemMedChem. 9(5). 973–983. 27 indexed citations

Hill, Richard, Ravi Kiran Reddy Kalathur, Sergio Callejas, et al.. (2014). A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes. Breast Cancer Research. 16(6). 482–482. 34 indexed citations

Madureira, Patrícia A., Richard Hill, Patrick W.K. Lee, & David M. Waisman. (2012). Genotoxic Agents Promote the Nuclear Accumulation of Annexin A2: Role of Annexin A2 in Mitigating DNA Damage. PLoS ONE. 7(11). e50591–e50591. 39 indexed citations

Pan, Da, et al.. (2011). Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation. British Journal of Cancer. 105(7). 1012–1022. 37 indexed citations

10.

Hill, Richard, Anna L. Greenshields, Mark Walsh, et al.. (2010). Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Letters. 297(1). 1–8. 117 indexed citations

11.

Chiu, Arthur, Xiangchao Shi, Richard Hill, et al.. (2010). Review of Chromium (VI) Apoptosis, Cell-Cycle-Arrest, and Carcinogenesis. Journal of Environmental Science and Health Part C. 28(3). 188–230. 88 indexed citations

12.

Hill, Richard & Patrick W. Lee. (2010). The DNA-dependent protein kinase (DNA-PK): More than just a case of making ends meet?. Cell Cycle. 9(17). 3460–3469. 77 indexed citations

13.

Leidal, Andrew M., et al.. (2009). p21^Cip1/WAF1mediates cyclin B1 degradation in response to DNA damage. Cell Cycle. 8(2). 253–256. 65 indexed citations

14.

Greenshields, Anna L., Richard Hill, Ashley L. Hilchie, et al.. (2009). Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Molecular Carcinogenesis. 49(1). 13–24. 121 indexed citations

15.

Hill, Richard, Andrew M. Leidal, Patrícia A. Madureira, et al.. (2008). Chromium-mediated apoptosis: Involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes. DNA repair. 7(9). 1484–1499. 26 indexed citations

16.

Blough, Michael, et al.. (2008). p53 binding to the p21 promoter is dependent on the nature of DNA damage. Cell Cycle. 7(16). 2535–2543. 49 indexed citations

17.

Hill, Richard, et al.. (2008). Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Experimental and Molecular Pathology. 84(3). 230–233. 68 indexed citations

18.

Hill, Richard. (2006). Duration of immunity (DOI) and booster vaccination—dealing with the issue at practice level in the UK. Veterinary Microbiology. 117(1). 93–97. 4 indexed citations

19.

Buluwela, Laki, Joanna Pike, Danish Mazhar, et al.. (2005). Inhibiting estrogen responses in breast cancer cells using a fusion protein encoding estrogen receptor-α and the transcriptional repressor PLZF. Gene Therapy. 12(5). 452–460. 13 indexed citations

20.

Hill, Richard & J Levin. (1986). Partial purification of thrombopoietin using lectin chromatography.. PubMed. 14(8). 752–9. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact